April 5-6

Grande Real Villa Itália Hotel, Cascais



Dear Friends and Colleagues, 

It is our pleasure and privilege to invite you to the Lisbon Stroke Summit which will be held in Cascais-Lisbon, on 5-6 April 2019.

Lisbon Stroke Summit aims to create a great scientific and networking success by providing a platform for international experts to discuss and compare experiences in cohesive and comprehensive sessions. Lisbon Stroke Summit enables participants to have the chance to benefit from scientific exchange during the formal activities. It is also an opportunity for participants to debate and discuss unresolved issues, highlight difficult clinical cases and discuss up-to-date scientific information essential to improve Stroke care. 

We would like you to join us at Lisbon Stroke Summit 2019. Don’t miss this international debate on the state of the art in acute stroke! Help us build knowledge in acute stroke! 


Sofia Galego Isabel Fragata Patrícia Ferreira 

LSS 2019, Co-Chairpersons 

Stroke care is multimodal, so the aim of this summit is to have a multidisciplinary approach to the treatment of acute ischemic stroke, so that together we can improve the care we offer. Consequently, Lisbon Stroke Summit Organizing Committee and Scientific Committee are multidisciplinary and comprise neurologists, internists and interventional neuroradiologists. 

Organizing Committee 

- Sofia Galego 

- Isabel Fragata 

- Patrícia Ferreira 

- Alberto Fior

-Bruno Maia

- Cristina Sousa 

- Jaime Pamplona 

- Mariana Baptista 

- Marisa Mariano

- Rui Carvalho 

Scientific Committee 

- Ana Paiva Nunes 

- Elsa Azevedo 

- João Alcântara 

- João Reis 

- Luísa Fonseca 

- Raul Nogueira 

Honorary Committee 

- Prof. Castro Lopes 

- Prof. Louis Caplan

- Prof. Jeffrey Saver 


Countless lectures
and activities

Hosts: Ana Paiva Nunes & Sofia Calado

Is IV rtPA in patients with LVO still beneficial?
     Pros: Yvo Roos
  Cons: João Reis, Portugal

rtPA vs tNK: it’s show time!
     Stick to what we know - rtPA:  Catarina Fonseca, Portugal     
       tNK has come to stay: Juan F. Arenillas, Spain

Case 1: 

Case 2: 
Expert multidisciplinary roundtable to discuss challenging cases in stroke.
NRL: Gustavo Santo
Internist: Teresa Mesquita 
NRI: Rui Carvalho

Anticoagulation: Balancing risk and benefit in challenging patients
SPEAKER: Pedro Monteiro, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

Hosts: Rita Silva & Isabel Fragata

Should EVT for LVO be offered to children?

Pros: Vitor M Pereira, Canada
Cons: Maja Steinlin, Switzerland

Moya Moya: bypass or conservative treatment?

Bypass: Domingos Coiteiro, Portugal
Conservative: Francesco Acerbi, Italy


Case 3: 

Case 4: 

Expert multidisciplinary roundtable to discuss challenging cases in stroke. 

NRL: Alexandre Amaral e Silva
Internist: Luísa Fonseca
NRI: José Manuel Amorim 
Role of in vitro studies in understanding the influence of techniques in mechanical thrombectomy
SPEAKER: Mahmood Mirza, Ireland

Hosts: Bruno Maia & Luísa Fonseca

Minimal invasive surgery for ICH?

Pros: David Fiorella, USA
Cons: Karin Klijn, Netherlands

Is there a role for reversal agents in anticoagulant associated ICH?

Pros: Jennifer Frontera, USA
Cons: Joao Sargento Freitas, Portugal

The future ain’t what it used to be! Artificial Intelligence and Stroke - Paul Bentley, UK

Precision Medicine in Stroke - Dietmar Frey, Germany

Open up your mind! Stem Cells  in Stroke - Lawrence R. Wechsler, USA

Case 5:

Case 6: 

Expert multidisciplinary roundtable to discuss challenging cases in stroke.

NRL: João Alcântara
Internist: Luisa Rebocho
NRI: Ricardo Veiga 

Host: Lia Neto

Speaker: J David Spence, Canada

Improved Recanalization Efficiency With the Newest Generation Aspiration Technology  
SPEAKER: Donald Frei, USA

Case 7:

Case 8: 

Expert multidisciplinary roundtable to discuss challenging cases in stroke. 

NRL: Diana Aguiar de Sousa
Internist: Paulo Chaves
NRI: Manuel Ribeiro 
A need for a tailored protection in our stroke patients
SPEAKER: Alexandre Amaral e Silva, Portugal

Host: Mariana Baptista

Speacker: Donald Frei, USA

Hosts: Carla Ferreira & Ângelo Carneiro

Do we still need selection criteria for acute LVO beyond 6h?

Pros: Simon Nagel, Germany
Cons: Raul Nogueira, USA

Can we prevent futile recanalization? 

Pros: Peter Vanacker, Belgium
Cons: Pasquale Mordasini, Switzerland


Get to know our professionals

Alexandre Amaral e Silva

HVFX, Lisbon, Portugal

Ana Paiva Nunes

CHULC, Lisbon, Portugal

Ângelo Carneiro

CHUP, Porto, Portugal

Bruno Maia

CHULC, Lisbon, Portugal

Carla Ferreira

H. Braga, Braga, Portugal

Catarina Fonseca

CHULN, Lisbon, Portugal

David Fiorella

Stony Brook University Hospital, New York, USA

Diana Aguiar de Sousa

CHULN, Lisbon, Portugal

Dietmar Frey

Charité University Medicine, Berlin - Germany

Domingos Coiteiro

CHULN, Hospital da Luz, Lisbon Portugal

Donald Frei

RIA, Denver, USA

Francesco Acerbi

Neurological Institute Carlo Besta, Milan, Italy

Gustavo Santo

CHUC, Coimbra, Portuga

Isabel Fragata

CHULC, Lisbon, Portugal

J. David Spence

SPARC, Ontario, Canada

Jeffrey Saver

UCLA, Los Angeles, USA

Jennifer Frontera

NYU Langone, New York, USA

João Alcântara

CMRA, Alcoitão, Portuga

João Reis

CHULC, Lisbon, Portugal

João Sargento Freitas

CHUC, Coimbra, Portugal

José Manuel Amorim

H. Braga, Portugal

Juan F. Arenillas

University of Valladolid, Hospital Clínico Universitario, Spain

Karin Klijn

Radboud University, Nijmegen, Netherlands

Lawrence R. Wechsler

University of Pittsburgh, USA

Lia Neto

CHULN, Lisbon, Portugal

Louis Caplan

Beth Israel Deaconess Medical Center, Boston, USA

Luísa Fonseca

CHUSJ, Porto, Portugal

Luísa Rebocho

HESE, Évora, Portugal

Mahmood Mirza

Neuravi, Galway, Ireland

Maja Steinlin

University Children's Hospital Inselspital, Bern, Switzerland

Manuel Ribeiro


Mariana Baptista


Pasquale Mordasini

University Hospital Inselspital, Bern, Switzerland

Paul Bentley

Faculty of Medicine, Imperial College London, UK

Paulo Castro Chaves

CHUSJ, Porto, Portugal

Pedro Monteiro

Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

Peter Vanacker

Antwerp University Hospital, Belgium

Raul Nogueira

Emory University, Atlanta, USA

Ricardo Veiga

CHUC, Coimbra, Portugal

Rita Silva


Rui Carvalho

CHULC, Lisbon, Portugal

Simon Nagel

Sofia Calado

CHLO, Lisbon, Portugal

Teresa Mesquita


Vitor M. Pereira

University of Toronto, Canada

Yvo Roos

AMC University, Amsterdam, Netherlands

Abstract Submission

Deadline -
March 3, 2019, 23:59 Western European Time (WET/GMT + 0)

(you'll need to create a user account)

Abstracts sent by email will not be accepted.

General Information

STEP 1: Title

Maximum 150 characters typed in lower-case letters, except for abbreviations. Make the title dynamic and conclusive, rather than descriptive. Do not include authors, institutions, city names, trademarks and abbreviations in the title.

STEP 2: Abstract Authors and Institutions

Your abstract must list at least 1 author in order to be submitted. If an author's name appears on more than one abstract, it must be identical on each abstract.

The submitting author is designated as the presenting author. You may rearrange the order of the authors; however, the senior author must always be listed last. The presenter must be an author of the abstract. You may enter up to 10 authors in the authors list including the Presenter.

The names of authors will be published as listed on the submission form. Please make sure you have entered the full list of authors and that the information given for each author is correct.

The authors' order and details (names, cities, country) will be published as entered by the submitter.

All correspondence will be sent only to the submitting author.

The submitter certifies that he/she has permission from all persons entered as co-authors in this abstract and that they are aware that their names will appear in all publications. The submitter signs and accepts responsibility for the present rules for submission and presentation on behalf of all co-authors.

STEP 3: Abstract Content

All abstracts must be submitted (and will be presented) in English using British English spelling with accurate grammar and spelling suitable for publication.

Abstracts must contain original material neither published nor presented elsewhere prior to the Lisbon Stroke Summit 2019 (in print or electronically).

Abstracts may have the following identifiable sections, but they are not mandatory:

  • Background
  • Objectives
  • Methods
  • Results
  • Conclusion(s)

The maximum abstract size is 25 lines (1 800 characters). The character limit does not include the title and the authors. Only the abstract text, table and spaces are taken into account. Do not begin sentences with numerals.

Abbreviations may be used after they are spelled out or defined. Is strictly prohibited the use of commercial drug names, brands and registered trademarks as well as company names, web sites and email addresses. Use generic names for all therapeutic agents.

Abstract Result

Abstract grading is blinded for review by 2 to 6 members of the Scientific Committee. Abstracts are selected on the basis of scientific merit. Each member of Scientific Committee is selected to review abstracts that best fits their expertise.

Abstracts submitted for consideration must be an original idea, concept, or an improvement or revision of a previous idea. Submissions are peer-reviewed for scientific content, logical presentation, and current interest of the topic to the scientific community.

The final selection will be made by the Lisbon Stroke Summit Scientific Committee in March 2019 and all abstract submitters will be notified by e-mail about the outcome (accepted or not accepted) of the review and selection process.

Guidelines for presentations will be provided to authors of accepted abstracts.

Lisbon Stroke Summit (LSS) will publish all accepted abstracts online (open access) in the International Journal of Clinical Neurosciences and Mental Health. As a condition of submission, Lisbon Stroke Summit requires you to agree to such publication and to surrender any copyright over the abstract as submitted to LSS.

Five cases will be chosen by the Scientific Committee to be a part of the "Elementary, my dear Watson" - Top 5 poster session to be held on April 6th .

The authors of the best posters will be invited to pick up the microphone and present their work in person during a dedicated session with the public and a multidisciplinary jury of internists, neurologists and interventionalists. The best abstracts will be announced after the presentations and will be awarded with:

  • Best Difficult Clinical Case - "HOUSTON WE HAVE A PROBLEM": 1 European Stroke Organization Conference 2020 registration and travel arrangements.
  • Best Poster "Top 5 - ELEMENTARY, MY DEAR WATSON": 1 Free Pass for the Stroke Scientific events in Portugal: AVC Portuguese Congress (SPAVC), NEDVC – SPMI Congress and Lisbon Stroke Summit

General Advice - Tips
  1. Keep language correct, simple and clear
  2. Avoid references cited in the abstract
  3. Stay away from complex graphics. Simple line or bar graphs work best. Make sure the font is adequate on each axis to be seen (insert the graphic as a Jpeg attachment and mention it in the abstract - ex.: Graphic 1)
  4. Ensure you follow all the practical guidance on the full call for abstracts
  5. Submit before the deadline, do not leave abstract writing until the 11th hour - this increases stress and leads to errors.

You can change/correct your abstract until the deadline submission. Log in to your account and access "my submissions".


Major Sponsor
Gold Sponsor
Silver Sponsors